Pharmaceuticals, Biotechnology and Life Sciences
Vaccine is intended to stimulate T cell responses against targets across the entire genome of the selected virus, similar to…
BPI France Logo BPI France Logo Arnaud Cutivet – CEO Arnaud Cutivet – CEO Arnaud Cutivet – CEO Arnaud Cutivet…
Psyence Group settles Debt for SharesTORONTO, March 10, 2025 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group” or the “Company”)…
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also…
Dupixent late-breaking positive pivotal data in bullous pemphigoid presented at AAD Five times more adults on Dupixent achieved sustained disease…
ESK-001 is a highly selective, next-generation oral tyrosine kinase 2 (TYK2) inhibitor currently under development in moderate-to-severe plaque psoriasis and…
ROCHESTER, N.Y., March 07, 2025 (GLOBE NEWSWIRE) — Vaccinex, Inc. (OTC: VCNX) (“Vaccinex” or the “Company”), a clinical-stage biotechnology company…
TAMPA, Fla., March 07, 2025 (GLOBE NEWSWIRE) — Better Choice Company Inc. (NYSE: BTTR) (“Better Choice” or the “Company”), a…
ALBANY, N.Y., March 07, 2025 (GLOBE NEWSWIRE) — Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization,…
TORONTO, March 07, 2025 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries”),…